Beckman Coulter and Fujirebio enter into partnership

The goal is a patient-friendly, blood-based Alzheimer's disease test

22-Sep-2023 - Beckman Coulter Diagnostics and Fujirebio announced a new partnership combining their respective immunoassay strengths to support therapeutic development, clinical trials, reimbursement, and routine clinical adoption in the field of neurodegenerative diseases. The burden of disability and deaths ...

Beckman Coulter Life Sciences acquires Dublin biotech start-up

15-Sep-2022 - Beckman Coulter Life Sciences announces it has acquired ValitaCell Ltd. Headquartered in Dublin, Ireland, ValitaCell creates analytical technologies and products for the biopharmaceutical industry with the goal of reducing new therapeutics' cost and time to market. Compared to other industry IgG ...

Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs

17-Nov-2020 - Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler, Germany. m2p-labs is best known for its transformative BioLector plate-based microbioreactors, which support automated solutions for screening and ...

Beckman Coulter strenghtens laboratory automation business

Acquires of acoustic liquid handling company

01-Feb-2019 - Beckman Coulter Life Sciences announced its acquisition of Labcyte, a privately held, acoustic liquid handling company based in San Jose, California. Labcyte is best known for its Echo® acoustic droplet ejection technology, which uses sound waves to transfer tiny amounts of liquid with ...

Beckman Coulter Cytometer accepted by WHO prequalification of in vitro diagnostics programme

01-Dec-2015 - Beckman Coulter Life Sciences announced that their Aquios CL flow cytometer has been accepted by the World Health Organization (WHO) Prequalification of In Vitro Diagnostics Programme. It can now be used specifically for the immunologic assessment of patients having, or suspected of having, ...

Beckman Coulter, Inc. Obtains CLIA Certificate, Licensure for Clinical Sequencing

11-May-2012 - Beckman Coulter, Inc. has obtained a CLIA Certificate of Registration, along with Massachusetts State Licensure, allowing Beckman Coulter Genomics to begin accepting clinical samples for genetic sequencing – the most technically complex CLIA category – and to provide those results to physicians ...

Danaher to Acquire Beckman Coulter, Inc. for $6.8 Billion

09-Feb-2011 - Danaher Corporation announced that it has entered into a definitive merger agreement with Beckman Coulter, Inc. pursuant to which Danaher will acquire Beckman Coulter by making a cash tender offer to acquire all of the outstanding shares of common stock of Beckman Coulter at a purchase price ...

Agilent Technologies Appoints Beckman Coulter Genomics First Certified Service Provider for Target Enrichment and Microarrays

08-Nov-2010 - Agilent Technologies Inc. and Beckman Coulter Genomics, Inc. announced that Beckman Coulter Genomics has achieved Certified Service Provider (CSP) status for the Agilent SureSelect Target Enrichment System, including new SureSelect XT which combines sequencing library preparation and gDNA ...

Beckman Coulter Announces the Creation of Beckman Coulter Genomics

New Company Offers Comprehensive Genomic Services

17-Aug-2009 - Beckman Coulter, Inc. announced the creation of Beckman Coulter Genomics. The new company, which combines Agencourt Bioscience and the newly acquired Cogenics, offers researchers a single genomic services resource with expanded global capabilities. "Through the creation of Beckman Coulter ...

Phenomenex to Distribute Beckman Coulter's IgY Proteome Enrichment Chemistry for Biomarker Discovery

11-Jun-2007 - Phenomenex Inc. announced a distribution agreement for Beckman Coulter's ProteomeLab IgY enrichment products for proteomics and biomarker discovery. The agreement grants Phenomenex exclusive distribution rights in the United States, Canada and countries in the European Union. According to the ...